UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000024438
Receipt No. R000028092
Scientific Title A Phase II, Open Label, Randomized Study of Osimertinib (TAgrisso) alone Versus Osimertinib plus Carboplatin/Pemetrexed for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed With Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Whose TUmours Harbour a T790M MutatIon Within the Epidermal Growth Factor Receptor Gene
Date of disclosure of the study information 2016/10/17
Last modified on 2017/10/17 11:38:02

No. Disposal Last modified on Item of update
1 Insert 2016/10/17 13:25:39
2 Update 2016/10/19 10:23:38 UMIN ID1
3 Update 2016/10/19 10:35:31 UMIN ID2
4 Update 2016/11/28 11:09:53 Recruitment status
Anticipated trial start date
5 Update 2017/10/17 11:38:03 Key inclusion criteria
Key inclusion criteria

Contact us.